Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Name: Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma
License: Public Domain

Second Affiliated Hospital, School of Medicine, Zhejiang University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

esophageal-squamous-cell-carcinoma

esophageal squamous cell carcinoma, neoadjuvant therapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261502
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.